PatrickWCobbMD

PubMed

• Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative a...
  Carlo Palmieri, Hannah Linden, Stephen N Birrell, Sally Wheelwright, Elgene Lim, Lee S Schwartzberg, Amy R Dwyer, Theresa E Hickey, Hope S Rugo, Patrick Cobb, Joyce A ...> ;The Lancet. Oncology. 2024 Mar 1
• 8 citations
  Overcoming Barriers to Referral for Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
  Marc S Hoffmann, Bradley D Hunter, Patrick W Cobb, Juan C Varela, Javier Munoz> ;Transplantation and Cellular Therapy. 2023 Jul 1
• 1 citations
  A review of the totality of evidence in the development of ABP 798, a rituximab biosimilar.
  Patrick Cobb, Dietger Niederwieser, Stanley Cohen, Caroline Hamm, Gerd Burmester, Neungseon Seo, Sonya G Lehto, Vladimir Hanes> ;Immunotherapy. 2022 Jun 1
• 2 citations
  Impact of early detection on cancer curability: A modified Delphi panel study.
  Lee Schwartzberg, Michael S Broder, Sikander Ailawadhi, Himisha Beltran, L Johnetta Blakely, G Thomas Budd, Laurie Carr, Michael Cecchini, Patrick Cobb, Anuraag Kansal...> ;Plos One. 2022 Jan 1
• 1 citations
  Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product.
  Dietger Niederwieser, Caroline Hamm, Patrick Cobb, Mindy Mo, Cecily Forsyth, Alessandra Tucci, Vladimir Hanes, Vincent Delwail, Roman Hajek, David Chien> ;Targeted Oncology. 2020 Dec 1
• 6 citations
  Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product.
  Dietger Niederwieser, Caroline Hamm, Patrick Cobb, Mindy Mo, Cecily Forsyth, Alessandra Tucci, Vladimir Hanes, Vincent Delwail, Roman Hajek, David Chien> ;Targeted Oncology. 2020 Oct 1
• 14 citations
  Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.
  Lee S. Schwartzberg, Gajanan Bhat, Julio Antonio Peguero, Richy Agajanian, Jayaram S. Bharadwaj, Alvaro Restrepo, Osama Hlalah, Inderjit Mehmi, Shanta Chawla, Steven J...> ;The Oncologist. 2020 Aug 1
• 12 citations
  A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic ch...
  Patrick Wayne Cobb, Yong Wha Moon, Klára Mezei, István Láng, Gajanan Bhat, Shanta Chawla, Steven J. Hasal, Lee S. Schwartzberg> ;Cancer Medicine. 2020 Jul 20
• 7 citations
  Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: a Southwest Oncology Group study.
  James H. Doroshow, Sheryl McCoy, Brian F. Issell, Taral Patel, Patrick W. Cobb, Kathleen J. Yost, James L. Abbruzzese> ;Investigational New Drugs. 2006 Jul 10
• Mixed-lineage acute myeloid leukemia associated with a suprasellar dysgerminoma.
  Krywicki R, Bowen K, Anderson L, Garland D, Cobb P, Jenkins T, O'Rourke T> ;Am. J. Clin. Oncol.. 1995-02-01
• 23 citations
  A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colon.
  John R. Eckardt, E. Campbell, H. A. Bums, Geoffrey R. Weiss, G. I. Rodriguez, Suzanne M. Fields, Allison Thurman, N. W. Peacock, Patrick W. Cobb, Mace L. Rothenberg, M...> ;American Journal of Clinical Oncology. 1994 Dec 1
• 37 citations
  Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion.
  Howard A. Burris, Ahmad Awada, J. G. Kuhn, J R Eckardt, Patrick W. Cobb, D A Rinaldi, S. Fields, L Smith, D. D. Von Hoff> ;Anti-Cancer Drugs. 1994 Aug 1
• Join now to see all